Les antidiabétiques oraux en 2003 = Oral antidiabetics in 2003DUCOBU, J.Revue médicale de Bruxelles. 2003, Vol 24, Num 4, pp A361-A368, issn 0035-3639Conference Paper

Molecular electrostatic potentials in the design of dendrimers for the delivery of glitazonesBHARATAM, Prasad V; SUNDRIYAL, Sandeep.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 3277-3282, issn 1533-4880, 6 p.Article

Therapeutical effects of PPAR agonists assessed by biomarker modulationCHINETTI-GBAGUIDI, G; FRUCHART, J.-C; STAELS, B et al.Biomarkers (London. Print). 2005, Vol 10, pp S30-S36, issn 1354-750X, SUP1Article

Diabète, cœur et glitozonesPHILIPPE, Jacques.Revue médicale de la Suisse romande. 2004, Vol 124, Num 3, pp 133-135, issn 0035-3655, 3 p.Conference Paper

Risque cardiovasculaire et glitazones = Cardiovoscular risk of glitazonesLEYE, Abdoulaye; ANDREELLI, Fabrizio; ROUSSEL, Ronan et al.STV. Sang thrombose vaisseaux. 2007, Vol 19, Num 1, pp 40-50, issn 0999-7385, 11 p.Article

PPARγ-mediated insulin sensitization: the importance of fat versus muscleKINTSCHER, Ulrich; LAW, Ronald E.American journal of physiology. Endocrinology and metabolism. 2005, Vol 51, Num 2, pp E287-E291, issn 0193-1849Article

Les glitazones = The glitazonesHALIMI, S.La Revue de médecine interne (Paris). 2005, Vol 26, Num 1, pp 54-57, issn 0248-8663, 4 p.Article

Diabète, glitazones et cœur = Diabetes, glitazones and heartLE FEUVRE, C.La Lettre du cardiologue. 2006, Num 392, pp 20-24, issn 0761-5035, 5 p.Article

Effects of pioglitazone and rosiglitazone on aortic vascular function in rat genetic hypertensionLLORENS, Silvia; MENDIZABAL, Yolanda; NAVA, Eduardo et al.European journal of pharmacology. 2007, Vol 575, Num 1-3, pp 105-112, issn 0014-2999, 8 p.Article

Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroidsGOTTFRIED, Eva; ROGENHOFER, Sebastian; KREUTZ, Marina et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 117-126, issn 0344-5704, 10 p.Article

Synergistic effects of troglitazone and oleate on the translatability of preproinsulin mRNA from INS-1 cellsBOLLHEIMER, L. Cornelius; KAGERBAUER, Simone M; BUETTNER, Roland et al.Biochemical pharmacology. 2002, Vol 64, Num 11, pp 1629-1636, issn 0006-2952, 8 p.Article

Tablet tips for type 2 diabetesPHILLIPS, Pat.Current therapeutics. 2000, Vol 41, Num 9, pp 71-76, issn 0311-905XArticle

Ostéoporose induite par les antidiabétiques = Osteoporosis induced by antidiabetic drugsLAFAGE-PROUST, Marie-Hélène.Revue du rhumatisme monographies (Print). 2011, Vol 78, Num 2, pp 88-93, issn 1878-6227, 6 p.Article

Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individualsZANCHI, A; MAILLARD, M; JORNAYVAZ, F. R et al.Diabetologia (Berlin). 2010, Vol 53, Num 8, pp 1568-1575, issn 0012-186X, 8 p.Article

Role of the PPAR-γ System in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal CellsMANNELLI, Massimo; CANTINI, Giulia; LUCONI, Michaela et al.Neuroendocrinology (Basel). 2010, Vol 92, pp 23-27, issn 0028-3835, 5 p., SUP1Conference Paper

MACULOPATHIE OEDEMATEUSE DIABÉTIQUE ASSOCIÉE AU TRAITEMENT PAR GLITAZONES: À PROPOS D'UN CASNYSSEN, V; HAUTENAUVEN, F; LEKEU HINOSTROZA, J. P et al.Bulletin de la Société belge d'ophtalmologie. 2009, Num 313, pp 39-44, issn 0081-0746, 6 p.Article

Prise en charge thérapeutique des stéatohépatites métaboliques : Foie métabolique = How to treat the nonalcoholic fatty liver disease?CADRANEL, Jean-François.Correspondances en MHDN. 2009, Vol 13, Num 6, pp 234-238, issn 2100-9619, 5 p.Article

Nouvelles thérapeutiques médicales dans la maladie de Cushing = New medical treatments in Cushing diseaseBRICAIRE, L; BRUE, T.Annales d'endocrinologie. 2007, Vol 68, issn 0003-4266, S18-S20, SUP1Article

Glitazones in the treatment of diabetes mellitus : clinical outcomes in large scale clinical trialsCHARBONNEL, Bernard.Fundamental & clinical pharmacology. 2007, Vol 21, pp 19-20, issn 0767-3981, 2 p., SUP2Conference Paper

Les glitazones : Un sursis d'aptitude pour les pilotes diabétiques = A reprieue for diabetic pilotsPARIS, J. F; LEDUC, P. A; PERRIER, E et al.Médecine aéronautique et spatiale. 2005, Vol 46, Num 172, pp 12-16, issn 0294-0817, 5 p.Article

Rôle des récepteurs nucléaires PPAR et ROR dans les cellules articulaires de la polyarthrite rhumatoïde = Role of nuclear receptors, PPAR and ROR, in articular cells of rheumatoid arthritisBIANCHI, Arnaud; MOULIN, David; TERLAIN, Bernard et al.Revue du rhumatisme (Ed. française). 2005, Vol 72, Num 4, pp 331-336, issn 1169-8330, 6 p.Article

Stratégie thérapeutique médicamenteuse du diabète de type 2: réflexion critique : Les nouveaux médicaments du diabète = Drug treatment strategy for type 2 diabetes: critical reflectionGRIMALDI, A.La Lettre du cardiologue. 2014, Num 473, pp 19-20, issn 0761-5035, 2 p.Article

The role of thiazolidinediones in non-alcoholic steatohepatitis - A systematic review and meta analysisMAHADY, Suzanne E; WEBSTER, Angela C; WALKER, Sarah et al.Journal of hepatology. 2011, Vol 55, Num 6, pp 1383-1390, issn 0168-8278, 8 p.Article

The socio-political roots of pharmaceutical uncertainty in the evaluation of 'innovative' diabetes drugs in the European Union and the USDAVIS, Courtney; ABRAHAM, John.Social science & medicine (1982). 2011, Vol 72, Num 9, pp 1574-1581, issn 0277-9536, 8 p.Article

Prise en charge thérapeutique des stéatohépatites métaboliques : Foie Métabolique = How to treat the nonalcoholic fatty liver disease?CADRANET, Jean-François.La Lettre de l'hépato-gastroentérologue. 2009, Vol 12, Num 3, pp 86-90, issn 1286-580X, 5 p.Article